Navigation Links
True Health Diagnostics Showcases Its Commitment to Educating Doctors, Patients About Hereditary Cancer During Breast Cancer Awareness Month
Date:10/11/2017

FRISCO, Texas, Oct. 11, 2017 /PRNewswire/ -- True Health, a leader in integrated diagnostics and healthcare services, has amplified its effort during National Breast Cancer Awareness month to educate doctors and patients about hereditary cancer risks.

Research recently published in the Journal of Clinical Oncology calculated that more than 10 million American women are at significant risk to have inherited mutations in BRCA1 or BRCA2 and have not had testing. These mutations can cause Hereditary Breast/Ovarian Cancer syndrome, which is associated with elevated lifetime risks for breast and ovarian cancers.

True Health Diagnostics, a subsidiary of True Health Group, earlier this year began offering hereditary cancer testing that can identify whether a person carries mutations in any of 26 different genes that increase the risk of developing breast, ovarian, colon, prostate, endometrial, gastric, melanoma or pancreatic cancer. True Health Diagnostics rolled out this testing platform to primary care and ob-gyn physicians, with the goal of reaching a broad group of patients who might not be aware of their hereditary cancer risks.

"True Health is redoubling our efforts during Breast Cancer Awareness Month to reach some of the millions of women who are eligible for testing, don't know it, and don't know whether they are at risk," said Chris Grottenthaler, CEO of True Health Group. "We're educating and empowering physicians to help reach these women, to determine their risk early on and address it proactively."

True Health Diagnostics last week conducted a series of educational webinars for primary care and other clinicians. Later this month, Ann Jeffers-Brown, True Health's clinical education manager for hereditary cancer testing, will speak about hereditary cancer at a luncheon at VA Bio+Tech Park in Richmond, Va.

"This effort is all about making sure people get the information they need, to understand exactly what their risks are," said Jeffers-Brown. "Every gene we test for has been determined to be 'clinically actionable,' which means if we find out you are at risk, there are specific things you can do to reduce that risk."

More information about True Health Diagnostics' hereditary cancer testing and what kind of personal and family history qualifies a person can be found on True Health's website.

About True Health

True Health Group is focused on transforming patient care through integrated diagnostics and healthcare services. True Health Diagnostics, a subsidiary, specializes in earlier-stage diagnosis and prevention of chronic disease, including cardiovascular, diabetes, cancer, genetic disorders and autoimmune disease. True Health is headquartered in Frisco, Texas, with operations across the country. More information can be found at truehealthdiag.com.

Media Contact:

Lon Wagner
Vice President, Communications
True Health Diagnostics
540-556-2994
Email: 180175@email4pr.com 
Website: http://www.truehealthdiag.com/

View original content with multimedia:http://www.prnewswire.com/news-releases/true-health-diagnostics-showcases-its-commitment-to-educating-doctors-patients-about-hereditary-cancer-during-breast-cancer-awareness-month-300534591.html


'/>"/>
SOURCE True Health Diagnostics
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Danish Health Tech Startup - Launching First-of-Its-Kind Mobile App to Help People Safely Manage, Taper Off Prescription Medications
2. DarioHealths MyDario to Appear on The Dr. Oz Show
3. PMD Healthcare Announces Collaboration with OptiMed Specialty Pharmacy
4. Zimmer Biomet Holdings to Present at Morgan Stanley 15th Annual Global Healthcare Conference
5. PDI Healthcare Hosts Educational Session at AVA 2017 on CHGs Role in CLABSI Prevention
6. President & CEO of Complete HealthCare Solutions, Inc., Responds to Wall Street Journal Report: Marlin Equity Seeks Buyer for eMDs
7. Hill-Rom to Present at the Morgan Stanley Global Healthcare Conference
8. Innovation Zed Explores New Models of Healthcare With the NHS in England
9. DarioHealth Closes on $5 Million Through Private Placement Offerings
10. DarioHealth Raises $4.28 Million Through Private Placement Offerings
11. DarioHealth to Host Second Quarter Conference Call on August 14, 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/11/2017)... Oct. 11, 2017  True Health, a leader ... its effort during National Breast Cancer Awareness month ... risks. Research ... calculated that more than 10 million American women ... in BRCA1 or BRCA2 and have not had testing. ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
Breaking Medicine News(10 mins):